Skip to main content
. 2014 Mar 25;9(3):e93050. doi: 10.1371/journal.pone.0093050

Figure 4. The activities of caspase-3 and caspase-7 treated with telmisartan in endometrial cancer cells.

Figure 4

The activities of caspase-3 and caspase-7 were assessed by Caspase-Glo 3/7 Assays. HHUA cells were treated with 100 μM telmisartan for 48 h. Control cells were treated with vehicle alone. Results represent the means ± SD of three independent experiments. Columns, means; bars, SDs. **P<0.01 vs. control.